Firefly Neuroscience, Inc. (AIFF) NASDAQ
1.58
+0.02(+1.28%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.58
+0.02(+1.28%)
Currency In USD
| Previous Close | 1.56 |
| Open | 1.55 |
| Day High | 1.59 |
| Day Low | 1.48 |
| 52-Week High | 4.51 |
| 52-Week Low | 0.62 |
| Volume | 585,224 |
| Average Volume | 10.62M |
| Market Cap | 23.37M |
| PE | -0.8 |
| EPS | -1.97 |
| Moving Average 50 Days | 1.44 |
| Moving Average 200 Days | 1.99 |
| Change | 0.02 |
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
Newsfile
Mar 06, 2025 12:30 PM GMT
A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementiaCalgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: